These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 27306080)

  • 1. Chondrocyte activity is increased in psoriatic arthritis and axial spondyloarthritis.
    Gudmann NS; Munk HL; Christensen AF; Ejstrup L; Sørensen GL; Loft AG; Karsdal MA; Bay-Jensen AC; He Y; Siebuhr AS; Junker P
    Arthritis Res Ther; 2016 Jun; 18(1):141. PubMed ID: 27306080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I and III collagen turnover is increased in axial spondyloarthritis and psoriatic arthritis. Associations with disease activity and diagnostic capacity.
    Gudmann NS; Siebuhr AS; Christensen AF; Ejstrup L; Sørensen GL; Loft AG; Karsdal MA; Bay-Jensen AC; Munk HL; Junker P
    Clin Exp Rheumatol; 2017; 35(4):653-659. PubMed ID: 28240584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.
    Munk HL; Gudmann NS; Christensen AF; Ejstrup L; Sorensen GL; Loft AG; Bay-Jensen AC; Siebuhr AS; Junker P
    Rheumatol Int; 2016 Apr; 36(4):541-9. PubMed ID: 26620690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential diagnostic value of a type X collagen neo-epitope biomarker for knee osteoarthritis.
    He Y; Manon-Jensen T; Arendt-Nielsen L; Petersen KK; Christiansen T; Samuels J; Abramson S; Karsdal MA; Attur M; Bay-Jensen AC
    Osteoarthritis Cartilage; 2019 Apr; 27(4):611-620. PubMed ID: 30654118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the C-reactive protein-to-albumin ratio the most remarkable simple inflammatory marker showing active disease in patients with axial spondyloarthritis, psoriatic arthritis, and rheumatoid arthritis?
    Kaplan H; Cengiz G; Şaş S; Eldemir YÖ
    Clin Rheumatol; 2023 Nov; 42(11):2959-2969. PubMed ID: 37470884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular matrix protein turnover markers are associated with axial spondyloarthritis-a comparison with postpartum women and other non-axial spondyloarthritis controls with or without back pain.
    Port H; Nielsen SH; Madsen SF; Bay-Jensen AC; Karsdal M; Seven S; Sørensen IJ; Morsel-Carlsen L; Østergaard M; Pedersen SJ
    Arthritis Res Ther; 2022 Jun; 24(1):152. PubMed ID: 35739562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum bone-turnover biomarkers are associated with the occurrence of peripheral and axial arthritis in psoriatic disease: a prospective cross-sectional comparative study.
    Jadon DR; Sengupta R; Nightingale A; Lu H; Dunphy J; Green A; Elder JT; Nair RP; Korendowych E; Lindsay MA; McHugh NJ
    Arthritis Res Ther; 2017 Sep; 19(1):210. PubMed ID: 28934972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammation.
    He Y; Siebuhr AS; Brandt-Hansen NU; Wang J; Su D; Zheng Q; Simonsen O; Petersen KK; Arendt-Nielsen L; Eskehave T; Hoeck HC; Karsdal MA; Bay-Jensen AC
    BMC Musculoskelet Disord; 2014 Sep; 15():309. PubMed ID: 25245039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
    Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
    Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using natural language processing to explore characteristics and management of patients with axial spondyloarthritis and psoriatic arthritis treated under real-world conditions in Spain: SpAINET study.
    Benavent D; Muñoz-Fernández S; De la Morena I; Fernández-Nebro A; Marín-Corral J; Castillo Rosa E; Taberna M; Sanabra C; Sastre C;
    Ther Adv Musculoskelet Dis; 2023; 15():1759720X231220818. PubMed ID: 38146537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raftlin - a potential biomarker for axial spondyloarthritis and psoriatic arthritis: An observational study.
    Yurdakul OV; Kara M; Ince B; Yildiz C; Yildiz T; Kilicoglu MS; Aydin T; Ozer OF
    Medicine (Baltimore); 2024 Jun; 103(26):e38770. PubMed ID: 38941376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor inhibitor dose adaptation in psoriatic arthritis and axial spondyloarthritis (TAPAS): a retrospective cohort study.
    Michielsens CAJ; den Broeder N; Mulder MLM; van den Hoogen FHJ; Verhoef LM; den Broeder AA
    Rheumatology (Oxford); 2022 May; 61(6):2307-2315. PubMed ID: 34599803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enthesitis in patients with psoriatic arthritis, axial spondyloarthritis and healthy subjects assessed by 'head-to-toe' whole-body MRI and clinical examination.
    Poggenborg RP; Eshed I; Østergaard M; Sørensen IJ; Møller JM; Madsen OR; Pedersen SJ
    Ann Rheum Dis; 2015 May; 74(5):823-9. PubMed ID: 24389294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel High Sensitivity Type II Collagen Blood-Based Biomarker, PRO-C2, for Assessment of Cartilage Formation.
    Luo Y; He Y; Reker D; Gudmann NS; Henriksen K; Simonsen O; Ladel C; Michaelis M; Mobasheri A; Karsdal M; Bay-Jensen AC
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis.
    Michelsen B; Ørnbjerg LM; Kvien TK; Pavelka K; Nissen MJ; Nordström D; Santos MJ; Koca SS; Askling J; Rotar Z; Gudbjornsson B; Codreanu C; Loft AG; Kristianslund EK; Mann HF; Ciurea A; Eklund KK; Vieira-Sousa E; Yazici A; Jacobsson L; Tomšič M; Löve TJ; Ionescu R; van der Horst-Bruinsma IE; Iannone F; Pombo-Suarez M; Jones GT; Hyldstrup LH; Krogh NS; Hetland ML; Østergaard M
    Rheumatology (Oxford); 2020 Sep; 59(9):2455-2461. PubMed ID: 31960053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE.
    Feist E; Baraliakos X; Behrens F; Thaçi D; Plenske A; Klaus P; Meng T
    Rheumatol Ther; 2024 Apr; 11(2):331-348. PubMed ID: 38308727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in axial spondyloarthritis diagnoses after the introduction of the ASAS criteria: a systematic review.
    Jamal M; van Delft ETAM; den Braanker H; Kuijper TM; Hazes JMW; Lopes Barreto D; Weel AEAM
    Rheumatol Int; 2023 Apr; 43(4):639-649. PubMed ID: 36637486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doppler enthesitis: a potential useful outcome in the assessment of axial spondyloarthritis and psoriatic arthritis.
    Molina Collada J; Macía-Villa C; Plasencia C; Álvaro-Gracia JM; de Miguel E
    Clin Rheumatol; 2021 May; 40(5):2013-2020. PubMed ID: 33034818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry.
    Ciurea A; Götschi A; Kissling S; Bernatschek A; Bürki K; Exer P; Nissen MJ; Möller B; Scherer A; Micheroli R
    RMD Open; 2023 Jun; 9(2):. PubMed ID: 37277211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.